Seroepidemiology of parechovirus A3 neutralizing antibodies, Australia, The Netherlands, and United States

Eveliina Karelehto, Lieke Brouwer, Kimberley Benschop, Jen Kok, Kerri Basile, Brendan McMullan, William Rawlinson, Julian Druce, Suellen Nicholson, Rangaraj Selvarangan, Christopher Harrison, Kamani Lankachandra, Hetty van Eijk, Gerrit Koen, Menno de Jong, Dasja Pajkrt, Katja C. Wolthers

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Recent parechovirus A3 (PeV-A3) outbreaks in Australia suggest lower population immunity compared with regions that have endemic PeV-A3 circulation. A serosurvey among populations in the Netherlands, the United States, and Australia before and after the 2013 Australia outbreak showed high PeV-A3 neutralizing antibody prevalence across all regions and time periods, indicating widespread circulation.
Original languageEnglish
Pages (from-to)148-152
JournalEmerging Infectious Diseases
Volume25
Issue number1
DOIs
Publication statusPublished - 1 Jan 2019
Externally publishedYes

Cite this

Karelehto, E., Brouwer, L., Benschop, K., Kok, J., Basile, K., McMullan, B., ... Wolthers, K. C. (2019). Seroepidemiology of parechovirus A3 neutralizing antibodies, Australia, The Netherlands, and United States. Emerging Infectious Diseases, 25(1), 148-152. https://doi.org/10.3201/eid2501.180352